European Journal of Cancer and Clinical Oncology
Volume 22, Issue 11, November 1986, Pages 1337-1345
Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study☆
References (29)
- et al.
Adjuvant methotrexate and citrovorum factor treatment of osteosarcoma
New Engl J Med
(1974) - et al.
High-dose methotrexate in osteogenic sarcoma
- et al.
Adjuvant chemotherapy and cis-diamminechlorplatinum (cysplatinum) in primary osteosarcoma
Cancer
(1981) - et al.
Adjuvant multiple drug chemotherapy for osteosarcoma of the extremities
Cancer
(1977) - et al.
Primary osteogenic sarcoma: eight years experience with adjuvant chemotherapy
J Cancer Res Clin Oncol
(1983) - et al.
Adjuvant chemotherapy in primary treatment of osteogenic sarcoma
Cancer
(1975) - et al.
Adriamycin (ADM) alone versus ADM and high dose methotrexate citrovorum factor rescue (HDMTX-CF) as adjuvant to operable primary osteosarcoma: a randomized study by cancer and leukemia gray B
- et al.
Osteosarcoma: a preliminary report of a trial of adjuvant chemotherapy
- et al.
Improved three-year disease-free survival in osteogenic sarcoma
Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience
Orthopedics
(1985)
Osteosarcoma
The treatment of osteosarcoma of the extremities: twenty years experience at the Istituto Ortopedico Rizzoli
Cancer
(1984)
Statistical aspects of the analysis of data from retrospective studies of disease
J Nat Cancer Inst
(1959)
Cited by (62)
Does intensified chemotherapy increase survival outcomes of osteosarcoma patients? A meta-analysis
2018, Journal of Bone OncologyCitation Excerpt :The obtained 12 studies were all comparative studies between intensified and conventional chemotherapy strategies. The characteristics of the 12 included studies were listed in Table 1 [15–26], of which 8 studies were RCT and 4 studies were CCT. A total of 4112 patients were involved in this meta-analysis.
Sarcomas of bone
2018, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of OncologyRelationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas
2018, Cancer Chemotherapy and PharmacologyChemotherapy for treating high-grade osteosarcoma in children and young adults
2018, Cochrane Database of Systematic Reviews
- ☆
Supported in part by a grant of the National Council for Research, project “Oncology” n. 84.00623.44.
Copyright © 1986 Published by Elsevier Ltd.